{
    "startDate": "2019-01-01",
    "endDate": "2019-03-31",
    "year": "2019",
    "quarter": "Q1",
    "symbol": "EYES",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 31682000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 597000
            },
            {
                "label": "Inventories, net",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 1602000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1155000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 35036000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 963000
            },
            {
                "label": "Right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 2508000
            },
            {
                "label": "Represents the information pertaining to deposits and other assets.",
                "concept": "eyes:DepositsAndOtherAssets",
                "unit": "usd",
                "value": 41000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 38548000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1600000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2309000
            },
            {
                "label": "Accrued compensation expense",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2080000
            },
            {
                "label": "Represents information pertaining to accrued clinical trial expenses.",
                "concept": "eyes:AccruedClinicalTrialExpenses",
                "unit": "usd",
                "value": 1016000
            },
            {
                "label": "Current operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 210000
            },
            {
                "label": "Contract liabilities",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 218000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 7433000
            },
            {
                "label": "Long term operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 2586000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10019000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, no par value, 10,000 shares authorized; none outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, no par value; 200,000 shares authorized; shares issued and outstanding: 124,198 and 76,336 as of March 31, 2019 and December 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 263418000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 46586000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -583000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -280892000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 28529000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 38548000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -9700000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 99000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 898000
            },
            {
                "label": "Non-cash lease expense",
                "concept": "OperatingLeaseExpense",
                "unit": "usd",
                "value": 6000
            },
            {
                "label": "Impairment charge",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 2424000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 95000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 786000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -236000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 297000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -57000
            },
            {
                "label": "Accrued compensation expenses",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -609000
            },
            {
                "label": "The increase (decrease) during the period in the carrying value of accrued clinical trial expenses reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).",
                "concept": "eyes:IncreaseDecreaseAccruedClinicalTrialExpenses",
                "unit": "usd",
                "value": 84000
            },
            {
                "label": "Contract liabilities",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 53000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -7150000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 37000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -37000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants.",
                "concept": "eyes:ProceedsFromIssuanceOfCommonStockAndWarrants",
                "unit": "usd",
                "value": 34399000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 34399000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Cash and cash equivalents:",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 27211000
            }
        ],
        "ic": [
            {
                "label": "Net sales",
                "concept": "RevenueFromContractWithCustomerIncludingAssessedTax",
                "unit": "usd",
                "value": 1128000
            },
            {
                "label": "Cost of sales",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 731000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 397000
            },
            {
                "label": "Research and development, net of grants",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 2183000
            },
            {
                "label": "The aggregate total amount of expenses directly related to clinical and regulatory of products and services.",
                "concept": "eyes:ClinicalAndRegulatoryExpense",
                "unit": "usd",
                "value": 1006000
            },
            {
                "label": "Selling and marketing",
                "concept": "SellingAndMarketingExpense",
                "unit": "usd",
                "value": 2103000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2449000
            },
            {
                "label": "Impairment charge",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 2424000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 10165000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -9768000
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 68000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -9700000
            },
            {
                "label": "Net loss per common share \u2013 basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.1
            },
            {
                "label": "Weighted average common shares outstanding \u2013 basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 96567000
            },
            {
                "label": "Foreign currency translation adjustments",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -8000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -9708000
            }
        ]
    }
}